News
Strides Arcolab Limited enters agreement to acquire 70 per cent of the Bangalore based biotechnology firm Inbiopro Solutions investinindia, India
View ArticleGilead Allows Generic HIV-Drug Sales in Developing Nations
Gilead Allows Generic HIV-Drug Sales in Developing Nations Bloomberg
View ArticleGilead inks low-cost HIV drug deal with generics makers
Gilead inks low-cost HIV drug deal with generics makers Fierce Pharma
View ArticlePfizer Seen Circling Agila With U.S. Drug Shortages
Pfizer Seen Circling Agila With U.S. Drug Shortages Bloomberg
View ArticlePfizer, Hospira likely shoppers for Indian injectables star Agila
Pfizer, Hospira likely shoppers for Indian injectables star Agila Fierce Pharma
View ArticleIndia's Strides Arcolab, Eli Lilly in generic cancer drug tie-up
India's Strides Arcolab, Eli Lilly in generic cancer drug tie-up Reuters
View ArticlePfizer Said to Weigh Purchase of Strides Unit Agila Specialties
Pfizer Said to Weigh Purchase of Strides Unit Agila Specialties Bloomberg
View ArticleMylan in exclusive talks to buy Strides Arcolab’s injectables unit
Mylan in exclusive talks to buy Strides Arcolab’s injectables unit Economic Times, India
View ArticleStrides Arcolab looks to sell stake worth Rs 4,885 cr
Strides Arcolab looks to sell stake worth Rs 4,885 cr Business Standard, India
View ArticleMylan to buy injectable drugs unit of India's Strides for $1.6 bln
Mylan to buy injectable drugs unit of India's Strides for $1.6 bln Reuters
View ArticleAllergan Targets Strides, Agila Over Generic Eye Drops
Allergan Targets Strides, Agila Over Generic Eye Drops Law 360
View ArticleUS approves Mylan's purchase of Strides unit, with conditions
US approves Mylan's purchase of Strides unit, with conditions Reuters
View ArticleStrides Arcolab invests in Oncobiologics Inc
Strides Arcolab invests in Oncobiologics Inc India TV News, India
View Article
